Steris | STE - Cash And Equivalent

Stock Price
264.27
Daily Change
2.60 0.99%
Monthly
2.93%
Yearly
19.67%
Q1 Forecast
254.51

Steris reported $319.2M in Cash and Equivalent for its fiscal quarter ending in September of 2025.





Cash And Equivalent Change Date
3M USD 5.24B 564M Dec/2025
Avanos Medical USD 70.5M 19.8M Sep/2025
Baxter International USD 1.73B 40M Sep/2025
Becton, Dickinson and Co. USD 641M 94M Sep/2025
Boston Scientific USD 1.28B 741M Sep/2025
CONMED USD 38.93M 4.99M Sep/2025
Cooper Companies USD 124.9M 13.3M Jun/2025
Dexcom USD 1.84B 676.7M Sep/2025
Ecolab USD 1.96B 34.9M Sep/2025
Edwards Lifesciences USD 2.69B 587.2M Sep/2025
Fortive USD 375.5M 55.3M Dec/2025
Getinge SEK 2.96B 720M Dec/2024
Globus Medical USD 229.45M 231.82M Jun/2025
Haemonetics USD 296.43M 3.53M Sep/2025
Hologic USD 2.17B 208.5M Dec/2025
Idexx Laboratories USD 208.17M 43.57M Sep/2025
Insulet USD 757.4M 364.2M Sep/2025
Integra LifeSciences USD 232.19M 14.27M Sep/2025
Intuitive Surgical USD 9.03B 601.6M Dec/2025
J&J USD 18.23B 10.35B Sep/2025
Masimo USD 312.3M 162.7M Sep/2025
Olympus JPY 241.22B 11.32B Jun/2025
Owens Minor USD 32.84M 5.42M Sep/2025
ResMed USD 1.42B 33.22M Dec/2025
Steris USD 319.2M 39.5M Sep/2025
Stryker USD 3.26B 881M Sep/2025
Tandem Diabetes Care USD 91.95M 27.83M Sep/2025
Teleflex USD 354M 100.3M Sep/2025
Thermo Fisher Scientific USD 9.85B 7.87B Dec/2025
Zimmer Biomet Holdings USD 1.29B 735.8M Sep/2025